Clinical trial
Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus…
NCT00074841 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00074841 |
|---|---|
| Title | Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India |
| Official title | A Phase II/III, Randomized, Comparative Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in India |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | PLASMODIUM FALCIPARUM MALARIA |
| Intervention type | Drug |
| Interventions | Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine |
| Enrollment | 230 |
| Start date | Sep 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Dec 24, 2003 |
| Last update posted | May 10, 2011 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: